Trial site
Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz
- 23running trials
- 16closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Asthma5 trials
- COPD5 trials
- Heart failure3 trials
- Obesity3 trials
- Ulcerative colitis3 trials
- Diabetic eye disease2 trials
- Follicular lymphoma2 trials
- Hidradenitis suppurativa2 trials
- Kidney cancer2 trials
- Macular degeneration2 trials
- Multiple myeloma2 trials
- Type 2 diabetes2 trials
- and 7 more
- Phase
- Phase 328 trials
- Phase 28 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Completed16 trials
- Active, not recruiting12 trials
- Recruiting10 trials
- Not yet recruiting1 trial
- Lead sponsor
- Chiesi Farmaceutici S.p.A.4 trials
- Sanofi4 trials
- AbbVie3 trials
- Amgen3 trials
- Genmab2 trials
- and 20 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Active, not recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Macular degeneration2 recruiting
- Obesity2 recruiting
- Asthma1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diabetic eye disease1 recruiting
- Hidradenitis suppurativa1 recruiting
- Multiple myeloma1 recruiting
- Vitiligo1 recruiting
Closed trials
Recruiting
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Completed
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026